Letters to the Editor

Outcomes of refractory or relapsed Hodgkin lymphoma patients with post-autologous stem cell transplantation brentuximab vedotin maintenance: a French multicenter observational cohort study

Department of Hematology, Hôpital Cochin, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France; Université de Paris, France; INSERM UMR 1163, Institut Imagine, Paris
Université de Paris, France; Department of Nuclear Medicine, Cochin Hospital, Assistance Publique-Hôpitaux de Paris (AP-HP), Paris
Cancer Research Center of Toulouse (CRCT), Team 9, INSERM UMR 1037, Toulouse
Department of Hematology, Hôpital Cochin, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France; Université de Paris
Lymphoma Academic Research Organization (LYSARC) Lymphoma Study Association Imaging, Hôpital Henri Mondor, Créteil, France; Paris Est University, Créteil
Department of Hematology, Hôpital Cochin, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France; Université de Paris
Hematology Department and INSERM U1151, Institut Necker Enfants Malades, Necker University Hospital, AP-HP, Paris
Lymphoma Academic Research Organization (LYSARC) Lymphoma Study Association Imaging, Hôpital Henri Mondor, Créteil
Department of Hematology, Nantes University Hospital, Nantes
Department of Hematology, Institut universitaire du cancer Toulouse- Oncopole, Toulouse
Lymphoid Malignancies Unit, Hôpital Henri Mondor, Créteil
Department of Haematology, Aix-Marseille University, Marseille
Department of Medical Oncology, Centre Léon Bérard, Lyon
Department of Haematology, Centre Hospitalier Universitaire Estaing, Clermont-Ferrand
Department of Hematology, Centre Henri Becquerel, Rouen
Department of Hematology, Clinique Louis Pasteur, Nancy
Department of Hematology, Institut Gustave-Roussy, Villejuif
Department of Hematology, CHU Besançon, Besançon
Strasbourg University Hospital, Strasbourg, France; INSERM S-1113, Strasbourg, France; Strasbourg University, Faculty of medicine, Strasbourg
Department of Hematology, Hôpital Saint Vincent de Paul, Lille
Department of Hematology, Hôpital Cochin, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris
Department of Hematology, Hôpital Lyon Sud, Pierre-Bénite, France; Société francophone de greffe de moelle et de thérapie cellulaire
Service de pathologie, Hôpital Cochin, APHP, France; Centre de recherche des Cordeliers, Sorbonne University, INSERM, Paris University
Société francophone de greffe de moelle et de thérapie cellulaire, France; Department of Hematology, CHRU Nancy, Hôpital Brabois; CNRS UMR 7365, Équipe 6, Biopôle de L'Université de Lorraine, Vandoeuvre-les-Nancy
Department of Hematology, Hôpital Cochin, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France; Université de Paris, France; Institut Cochin, INSERM U1016, Paris
Department of Hematology, University of Montpellier, Montpellier
Department of Hematology, Dijon University Hospital, Dijon, France; INSERM UMR 1231 CHU Dijon
Department of Hematology, CHU Paris-GH St-Louis Lariboisière F-Widal - Hôpital Saint-Louis, Paris
Department of Hematology, Centre Hospitalier Lyon Sud, Pierre-Bénite
Department of Hematology, Hôpital Cochin, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France; Université de Paris, France; Institut Cochin, INSERM U1016, Paris, France; Translational Research Centre in Onco-hematology, Faculty of Medicine, University of Geneva, 1211, Geneva 4
Department of Hematology, Hôpital Cochin, Assistance Publique - Hôpitaux de Paris (AP-HP), Paris, France; Université de Paris
Haematologica Early view Dec 30, 2021 https://doi.org/10.3324/haematol.2021.279564